30th Mar 2009 17:30
Transaction by Persons Discharging Managerial Responsibilities
Disclosure Rules DR 3.1.4R
We hereby inform you that on 27 March 2009 the following Directors of AstraZeneca PLC were each granted an award under the terms of the AstraZeneca Performance Share Plan over the Company's USD0.25 Ordinary Shares.
|
Name of Director |
Target number of shares awarded |
Award price per share |
Normal vesting date |
Total interest in shares after this award |
Percentage of shares in issue |
|
D R Brennan |
133,347 |
2280p |
27 March 2012 |
See below |
See below |
|
S Lowth |
54,276 |
2280p |
27 March 2012 |
140,243 |
0.01% |
The AstraZeneca Performance Share Plan was approved by shareholders at the Company's AGM in 2005. Awards made under the Plan may not generally vest before the third anniversary of the relevant date of grant nor unless the specified performance target(s) have been met at the end of the three year period which, for this award, is 1 January 2009 to 31 December 2011.
The performance target that applies to this award is the Company's Total Shareholder Return ("TSR") compared to the TSR of a selected peer group of 12 other pharmaceutical companies. The actual number of shares to which a participant may become unconditionally entitled will depend on the extent to which the performance target(s) have been met. A summary of the Plan, including a more detailed explanation of the performance target(s), can be found in the AstraZeneca Annual Report and Form 20-F Information 2008 which is available on the Company's website www.astrazeneca.com.
Mr Brennan has interests in the Company's Ordinary Shares and American Depositary Shares (ADSs). One ADS equals one Ordinary Share. In total, Mr Brennan now has an interest in 509,988 Ordinary Shares and 76,188 ADSs, which together represent approximately 0.04% of the number of shares currently in issue.
A C N Kemp
Company Secretary
30 March 2009
Related Shares:
Astrazeneca